Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Medicure News

    0,71 € +6,77% +0,045 €
    10:54:38 Uhr Frankfurt aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A1J7TZ
    ISIN: CA58469E4085
    US-Symbol: MCUJF
    Typ: Aktie

    Medicure News

    11.11.20 - PR Newswire
    Medicure Reports Financial Results for Quarter Ended September 30, 2020
    Medicure Reports Financial Results for Quarter Ended September 30, 2020 PR Newswire
    05.11.20 - PR Newswire
    Medicure Q3 2020 Results and Conference Call Dates
    Medicure Q3 2020 Results and Conference Call Dates PR Newswire
    05.10.20 - PR Newswire
    Medicure announces an agreement with Reliance Life Sciences for the marketing rights of a cardiovascular biosimilar
    Medicure announces an agreement with Reliance Life Sciences for the marketing rights of a cardiovascular biosimilar PR Newswire
    24.08.20 - PR Newswire
    Medicure Announces AGGRASTAT® Shows Promise in Treating Thrombotic Complications Due to COVID-19 in Early Clinical Reports
    Medicure Announces AGGRASTAT® Shows Promise in Treating Thrombotic Complications Due to COVID-19 in Early Clinical Reports PR Newswire
    20.08.20 - PR Newswire
    Medicure Announces Termination of ReDSTM Pro Marketing and Distribution Agreement
    Medicure Announces Termination of ReDSTM Pro Marketing and Distribution Agreement PR Newswire
    05.08.20 - PR Newswire
    Medicure Q2 2020 Results and Conference Call Dates
    Medicure Q2 2020 Results and Conference Call Dates PR Newswire
    29.06.20 - PR Newswire
    Medicure Announces Normal Course Issuer Bid
    Medicure Announces Normal Course Issuer Bid PR Newswire
    29.06.20 - PR Newswire
    Medicure Announces Positive Results for AGGRASTAT® in the FABOLUS-FASTER Trial and Publication in the Journal - Circulation
    Medicure Announces Positive Results for AGGRASTAT® in the FABOLUS-​FASTER Trial and Publication in the Journal - Circulation PR Newswire
    25.06.20 - PR Newswire
    Medicure Announces a Direct to Patient Online Pharmacy Program for Distribution of ZYPITAMAG™ (Pitavastatin) Tablets
    Medicure Announces a Direct to Patient Online Pharmacy Program for Distribution of ZYPITAMAG™ (Pitavastatin) Tablets PR Newswire
    18.06.20 - PR Newswire
    C-Suite At The Open: Albert Friessen, Chair & CEO from Medicure Inc. tells his Company story. Filmed May 2020.
    C-Suite At The Open: Albert Friessen, Chair & CEO from Medicure Inc. tells his Company story. Filmed May 2020. Canada NewsWire
    15.06.20 - PR Newswire
    Medicure Announces Top Line Data from FABOLUS-FASTER Trial With AGGRASTAT® will be Presented at the PCR e-Course, Late Breaking Trial Sessions, June 27, 2020
    Medicure Announces Top Line Data from FABOLUS-​FASTER Trial With AGGRASTAT® will be Presented at the PCR e-Course, Late Breaking Trial Sessions, June 27, 2020 PR ...
    06.05.20 - PR Newswire
    Medicure Q1 2020 results and conference call dates
    Medicure Q1 2020 results and conference call dates PR Newswire
    15.04.20 - PR Newswire
    Medicure Reports Financial Results for Quarter and Year Ended December 31, 2019
    Medicure Reports Financial Results for Quarter and Year Ended December 31, 2019 PR Newswire
    13.04.20 - PR Newswire
    Medicure To Announce Fiscal Year End 2019 Financial Results on April 15, 2020
    Medicure To Announce Fiscal Year End 2019 Financial Results on April 15, 2020 PR Newswire
    31.12.19 - PR Newswire
    Early Warning News Release - Dr. Albert D. Friesen Holdings in Medicure Inc.
    Early Warning News Release - Dr. Albert D. Friesen Holdings in Medicure Inc. PR Newswire
    20.12.19 - PR Newswire
    Medicure Announces Preliminary Results of Substantial Issuer Bid
    Medicure Announces Preliminary Results of Substantial Issuer Bid PR Newswire
    17.12.19 - PR Newswire
    Medicure Announces the Completion of Shortened AGGRASTAT® Versus Integrilin® in Percutaneous Coronary Intervention (SAVI-PCI) Study
    Medicure Announces the Completion of Shortened AGGRASTAT® Versus Integrilin® in Percutaneous Coronary Intervention (SAVI-PCI) Study PR Newswire
    12.12.19 - PR Newswire
    Medicure Announces Completion of Enrollment for FABOLUS-FASTER, Phase 4 Clinical Trial of Aggrastat (Tirofiban Hydrochloride) Injection VS Kengreal (Cangrelor) in Patients Undergoing Percutaneous Coronary Intervention (PCI)
    Medicure Announces Completion of Enrollment for FABOLUS-​FASTER, Phase 4 Clinical Trial of Aggrastat (Tirofiban Hydrochloride) Injection VS Kengreal (Cangrelor) in Patients ...
    05.12.19 - PR Newswire
    Medicure Files Patent Infringement Action
    Medicure Files Patent Infringement Action PR Newswire
    05.12.19 - PR Newswire
    Medicure Announces Settlement of Holdback Dispute from Apicore Sale
    Medicure Announces Settlement of Holdback Dispute from Apicore Sale PR Newswire

    Newssuche

    Videos

    newspaper
    09:15 Uhr -8,87%
    Technical Trading: Sojabohnen Long bis Juli
    Sojabohnen Long Typ: Turbo Open End WKN: VX41AH Hebel: 5 Laufzeit: OpenEnd Einstieg: Market ... Mehr »